• Je něco špatně v tomto záznamu ?

US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory

L. Piemonti, A. Andres, J. Casey, E. de Koning, M. Engelse, R. Hilbrands, P. Johnson, B. Keymeulen, J. Kerr-Conte, O. Korsgren, R. Lehmann, T. Lundgren, P. Maffi, F. Pattou, F. Saudek, J. Shaw, H. Scholz, S. White, T. Berney

. 2021 ; 34 (7) : 1182-1186. [pub] 20210611

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025504

Allogeneic islet transplantation is a standard of care treatment for patients with labile type 1 diabetes in many countries around the world, including Japan, the United Kingdom, Australia, much of continental Europe, and parts of Canada. The United States is now endorsing islet cell treatment for type 1 diabetes, but the FDA has chosen to consider islets as a biologic that requires licensure, making the universal implementation of the procedure in the clinic very challenging and opening the manufacture of islet grafts to private companies. The commercialization of human tissues raises significant legal and ethical issues and ironically leads to a situation where treatments developed as a result of the scientific and economic efforts of academia over several decades become exploited exclusively by for-profit entities.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025504
003      
CZ-PrNML
005      
20211026133740.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/tri.13930 $2 doi
035    __
$a (PubMed)34048106
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Piemonti, Lorenzo $u Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
245    10
$a US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory / $c L. Piemonti, A. Andres, J. Casey, E. de Koning, M. Engelse, R. Hilbrands, P. Johnson, B. Keymeulen, J. Kerr-Conte, O. Korsgren, R. Lehmann, T. Lundgren, P. Maffi, F. Pattou, F. Saudek, J. Shaw, H. Scholz, S. White, T. Berney
520    9_
$a Allogeneic islet transplantation is a standard of care treatment for patients with labile type 1 diabetes in many countries around the world, including Japan, the United Kingdom, Australia, much of continental Europe, and parts of Canada. The United States is now endorsing islet cell treatment for type 1 diabetes, but the FDA has chosen to consider islets as a biologic that requires licensure, making the universal implementation of the procedure in the clinic very challenging and opening the manufacture of islet grafts to private companies. The commercialization of human tissues raises significant legal and ethical issues and ironically leads to a situation where treatments developed as a result of the scientific and economic efforts of academia over several decades become exploited exclusively by for-profit entities.
650    12
$a diabetes mellitus 1. typu $x chirurgie $7 D003922
650    _2
$a lidé $7 D006801
650    12
$a Langerhansovy ostrůvky $7 D007515
650    12
$a transplantace Langerhansových ostrůvků $7 D016381
650    _2
$a Úřad Spojených států pro potraviny a léky $7 D014486
651    _2
$a Austrálie $7 D001315
651    _2
$a Evropa $7 D005060
651    _2
$a Japonsko $7 D007564
651    _2
$a Spojené království $7 D006113
651    _2
$a Spojené státy americké $7 D014481
655    _2
$a časopisecké články $7 D016428
700    1_
$a Andres, Axel $u Department of Surgery, Geneva University Hospitals, Geneva, Switzerland
700    1_
$a Casey, John $u Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK
700    1_
$a de Koning, Eelco $u Department of Internal Medicine and Transplantation Center, Leiden University Medical Center, Leiden, the Netherlands
700    1_
$a Engelse, Marten $u Department of Internal Medicine and Transplantation Center, Leiden University Medical Center, Leiden, the Netherlands
700    1_
$a Hilbrands, Robert $u Diabetes Research Center (DRC), Vrije Universiteit Brussel (VUB), Brussels, Belgium
700    1_
$a Johnson, Paul $u Nuffield Department of Surgical Sciences and Oxford Biomedical Research Centre (OxBRC), Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM), University of Oxford, Oxford, UK
700    1_
$a Keymeulen, Bart $u Diabetes Research Center (DRC), Vrije Universiteit Brussel (VUB), Brussels, Belgium
700    1_
$a Kerr-Conte, Julie $u Translational Research for Diabetes, Inserm, Centre Hospitalier Universitaire Lille, Lille Pasteur Institute, U1190, European Genomic Institute for Diabetes, University of Lille, Lille, France
700    1_
$a Korsgren, Olle $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
700    1_
$a Lehmann, Roger $u Department Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland
700    1_
$a Lundgren, Torbjörn $u Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
700    1_
$a Maffi, Paola $u Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
700    1_
$a Pattou, Francois $u Translational Research for Diabetes, Inserm, Centre Hospitalier Universitaire Lille, Lille Pasteur Institute, U1190, European Genomic Institute for Diabetes, University of Lille, Lille, France
700    1_
$a Saudek, Frantisek $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Shaw, James $u Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
700    1_
$a Scholz, Hanne $u Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway
700    1_
$a White, Steve $u Department of HPB and Transplant Surgery, The Freeman Hospital, Newcastle Upon Tyne, UK
700    1_
$a Berney, Thierry $u Department of Surgery, Geneva University Hospitals, Geneva, Switzerland
773    0_
$w MED00004553 $t Transplant international : official journal of the European Society for Organ Transplantation $x 1432-2277 $g Roč. 34, č. 7 (2021), s. 1182-1186
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34048106 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133746 $b ABA008
999    __
$a ok $b bmc $g 1714527 $s 1146011
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 34 $c 7 $d 1182-1186 $e 20210611 $i 1432-2277 $m Transplant international $n Transpl Int $x MED00004553
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace